Betaine
RDCRN 5204
Unknown small_molecule completed
Quick answer
Betaine for Angelman Syndrome is a Unknown program (small_molecule) at Ultragenyx Pharmaceutical with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Ultragenyx Pharmaceutical
- Indication
- Angelman Syndrome
- Phase
- Unknown
- Modality
- small_molecule
- Status
- completed